Moderna tests Four-in-One mRNA vaccine cocktail in groundbreaking safety trial
NCT ID NCT05397223
Summary
This study tested the safety and immune response of several Moderna mRNA vaccines designed to protect against four different viruses: COVID-19, seasonal flu, respiratory syncytial virus (RSV), and cytomegalovirus (CMV). It involved 308 healthy adults aged 18 to 75. The main goal was to check for side effects and see how well the vaccines triggered protective antibodies in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV-2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Benchmark Research
Austin, Texas, 78705, United States
-
CenExel
Hollywood, Florida, 33024, United States
-
DM Clinical Research- Texas Center for Drug Development
Houston, Texas, 77081, United States
-
Johnson County Clinical Trials
Lenexa, Kansas, 66219, United States
-
Meridian Clinical Research
Savannah, Georgia, 31406, United States
-
Meridian Clinical Research
Sioux City, Iowa, 51106, United States
-
Meridian Clinical Research
Lincoln, Nebraska, 68510, United States
-
Tekton Research, Inc
Austin, Texas, 78745, United States
Conditions
Explore the condition pages connected to this study.